Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TrialNet’s ASCEND T1D trial compares ATG with teplizumab to explore new ways to delay progression of Stage 2 type 1 diabetes.
Read More »Teplizumab Has Competition: A Head-to-Head Trial Could Reshape Type 1 Diabetes Prevention
© Copyright 2026 DiabetesInControl.com, All Rights Reserved.